PDL BioPharma, Inc. (NASDAQ:PDLI) closed December 29 at $2.74, down -22.82% or $0.81 from its record high price of $3.55. Looking at the other side of the coin, PDLI traded as low as $1.96 in the past 52 weeks, and since then the shares have risen 39.8 ...
more»